Glenmark Specialty S.a.

Lupin Atlantis Holdings Sa

Franciscus Koppenhagen

Ulhas R Dhuppad

Chandrakant Dhatrak

Sunil Chaudhari

Suresh Rajurkar

Alkesh Kasliwal

Julianne Berry

Abhishek Gupta

Herbert Clark Chiou

Samiran De

Xian-Ming Zeng

Ramprasad Murugan

Mahadeorao S Rase

The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.

Tiotropium inhalation solution for nebulization

The invention relates to processes for dry powder blending. Specifically the invention relates to dry powder blending of pharmaceutical and non-pharmaceutical solid particulate matter and powders. More specifically the invention relates to dry powder blending of microparticles, and to dry powder blends for use as pharmaceuticals. In particular, the present invention relates to a process of preparing a dry microparticulate powder blend comprising one or more micronized active pharmaceutical ingredient(s) (API) and optionally, one or more micronized or non-micronized pharmaceutically acceptable carrier(s) and/or excipient(s), wherein the process comprises the steps of 'pulsating blending' of the micronized active pharmaceutical ingredient(s) and the pharmaceutically acceptable carrier(s) and/or excipient(s).

Process for manufacturing dry powder blends

The present disclosure relates to a nebulization composition comprising tiotropium and formoterol for the treatment of inflammatory or obstructive airway disease. The present disclosure also relates to a process for preparing the composition.

Nebulizable compositions of tiotropium and formoterol

Growing community of inventors

Deerfield Beach, FL, United States of America

Franciscus Koppenhagen